葛根素
下调和上调
PI3K/AKT/mTOR通路
癌症
癌症研究
细胞凋亡
癌细胞
药理学
激酶
医学
生物
化学
细胞生物学
生物化学
内科学
病理
基因
替代医学
作者
Manikanta Murahari,Vikas Singh,Pramila Chaubey,Vasanti Suvarna
出处
期刊:Anti-cancer Agents in Medicinal Chemistry
[Bentham Science]
日期:2020-03-02
卷期号:20 (6): 678-686
被引量:13
标识
DOI:10.2174/1871520620666200227091811
摘要
Cancer is one of the prominent global causes of death and the foremost worldwide health concern. Despite unprecedented progress in cancer chemoprevention, a vast number of cancers, however, remain an undefeatable challenge for treatment modalities. Immense therapeutic activities of puerarin contribute to its use in various health disorders. In this review, we explored the potential molecular mechanisms and targets of puerarin, proving its potential as a novel anticancer agent, for future cancer therapy and chemoprevention. Several mechanisms account for anticancer activity of puerarin which includes downregulation of NF-kB signalling pathway, mTOR signalling pathway, PI3K and BCl-2 proteins and upregulation of miR-16, caspase proteins, c- Jun N terminal kinase and extracellular signal-regulated kinase 1/2. These alterations result in inhibition of cancer cell proliferation and/or induction of apoptosis. Understanding the molecular mechanisms involved in chemotherapy and chemoprevention could aid in the more pronounced exploration of puerarin in effective cancer treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI